273 related articles for article (PubMed ID: 10520611)
1. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
[TBL] [Abstract][Full Text] [Related]
2. Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.
Rappley MD; Eneli IU; Mullan PB; Alvarez FJ; Wang J; Luo Z; Gardiner JC
J Dev Behav Pediatr; 2002 Feb; 23(1):23-30. PubMed ID: 11889348
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
Guevara J; Lozano P; Wickizer T; Mell L; Gephart H
Pediatrics; 2002 May; 109(5):733-9. PubMed ID: 11986429
[TBL] [Abstract][Full Text] [Related]
4. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
5. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
6. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Chen CY; Gerhard T; Winterstein AG
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
[TBL] [Abstract][Full Text] [Related]
7. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
Houghton R; Liu C; Bolognani F
Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
[TBL] [Abstract][Full Text] [Related]
8. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
Winterstein AG; Soria-Saucedo R; Gerhard T; Correll CU; Olfson M
J Clin Psychiatry; 2017 Jul; 78(7):e744-e781. PubMed ID: 28686819
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
10. Attention-Deficit/Hyperactivity Disorder and Psychotropic Polypharmacy Prescribing Trends.
Girand HL; Litkowiec S; Sohn M
Pediatrics; 2020 Jul; 146(1):. PubMed ID: 32487590
[TBL] [Abstract][Full Text] [Related]
11. Psychotropic Polypharmacy Among Children and Youth Receiving Medicaid, 2012-2015.
Lohr WD; Creel L; Feygin Y; Stevenson M; Smith MJ; Myers J; Woods C; Liu G; Davis DW
J Manag Care Spec Pharm; 2018 Aug; 24(8):736-744. PubMed ID: 30058983
[TBL] [Abstract][Full Text] [Related]
12. Psychotropic drug use among preschool children in the Medicaid program from 36 states.
Garfield LD; Brown DS; Allaire BT; Ross RE; Nicol GE; Raghavan R
Am J Public Health; 2015 Mar; 105(3):524-9. PubMed ID: 25602884
[TBL] [Abstract][Full Text] [Related]
13. Treatment modalities among US children diagnosed with attention-deficit hyperactivity disorder: 1995-99.
Robison LM; Sclar DA; Skaer TL; Galin RS
Int Clin Psychopharmacol; 2004 Jan; 19(1):17-22. PubMed ID: 15101565
[TBL] [Abstract][Full Text] [Related]
14. Health care utilization by children with chronic illnesses: a comparison of medicaid and employer-insured managed care.
Shatin D; Levin R; Ireys HT; Haller V
Pediatrics; 1998 Oct; 102(4):E44. PubMed ID: 9755281
[TBL] [Abstract][Full Text] [Related]
15. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
[TBL] [Abstract][Full Text] [Related]
16. Prescribing for young people with attention deficit hyperactivity disorder in UK primary care: analysis of data from the Clinical Practice Research Datalink.
Newlove-Delgado T; Hamilton W; Ford TJ; Stein K; Ukoumunne OC
Atten Defic Hyperact Disord; 2019 Sep; 11(3):255-262. PubMed ID: 30730035
[TBL] [Abstract][Full Text] [Related]
17. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
18. Psychotropic Treatment Pattern in Medicaid Pediatric Patients With Concomitant ADHD and ODD/CD.
Liu X; Shah V; Kubilis P; Xu D; Bussing R; Winterstein AG
J Atten Disord; 2019 Jan; 23(2):140-148. PubMed ID: 26269095
[TBL] [Abstract][Full Text] [Related]
19. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
Fullerton CA; Epstein AM; Frank RG; Normand SL; Fu CX; McGuire TG
Psychiatr Serv; 2012 Feb; 63(2):115-21. PubMed ID: 22302327
[TBL] [Abstract][Full Text] [Related]
20. National trends in the treatment of attention deficit hyperactivity disorder.
Olfson M; Gameroff MJ; Marcus SC; Jensen PS
Am J Psychiatry; 2003 Jun; 160(6):1071-7. PubMed ID: 12777264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]